NCT05036720 (LTP+Dads) is a NA clinical trial of LTP+Dads in Depression, sponsored by Pakistan Institute of Living and Learning.

Who is sponsoring NCT05036720?

NCT05036720 is sponsored by Pakistan Institute of Living and Learning.

What drugs are being tested in NCT05036720?

Interventions in NCT05036720: LTP+Dads, LTP+ Optional mother component.

What condition does NCT05036720 study?

NCT05036720 studies Depression.

Is NCT05036720 still recruiting?

NCT05036720 is currently completed. Last updated 17 May 2024.

Last reviewed 2024-05-17 · How we verify

NCT05036720: LTP+Dads

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LTP Plus Dads-Partner Inclusive Intervention for Depressed Fathers in Pakistan

Completed NA Last updated 17 May 2024

What this trial tests

NA trial testing LTP+Dads in Depression in 2,884 participants. Completed in 30 December 2023.

Timeline

10 September 2021

Primary endpoint
30 March 2023

30 December 2023

Quick facts

Lead sponsor	Pakistan Institute of Living and Learning
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	2,884
Start date	10 September 2021
Primary completion	30 March 2023
Estimated completion	30 December 2023
Sites	1 location across Pakistan

Drugs / interventions tested

LTP+Dads
LTP+ Optional mother component

Conditions studied

Depression — all drugs for Depression →

Sponsor

Pakistan Institute of Living and Learning

Who can join

18 and older, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to support and equip fathers and mothers with cognitive behavioral tools and knowledge about child development to be effective in their role as co-parent and partner, leading to improvement in paternal depression. Objectives: * To evaluate the clinical and cost effectiveness of the Learning Through Play+ (LTP + ) intervention in reducing depression in fathers and mothers. * To evaluate the effectiveness of the LTP+ intervention in improving child outcomes. * Process evaluation and identifying challenges in transition to scale up of the intervention across Karachi, Pakistan from the perspective of fathers, mothers, and other stakeholders.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Lived experiences of mothers with postnatal anxiety: a qualitative phenomenology study from Pakistan.
Saeed Q, Shafique K, Chaudhry N. · · 2024 · cited 2× · PMID 38772885 · DOI 10.1136/bmjopen-2023-078203

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Pakistan Institute of Living and Learning trials

Trials by the same sponsor.

NCT07015944 — Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan · NA · recruiting
NCT06442007 — Universally Delivered Interventions for Young People · NA · not yet recruiting
NCT07188597 — Culturally Adapted Cognitive Behavior Therapy for Individuals At Risk of First Episode Psychosis · NA · recruiting
NCT03974620 — Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia · NA · not yet recruiting
NCT05933850 — Culturally Adapted Strong Families Programme for Families Living in Gilgit Baltistan, Pakistan · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05036720 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pakistan Institute of Living and Learning
Last refreshed: 17 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05036720.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing